Source: Eur Respir J, 57 (2) 2002122; 10.1183/13993003.02122-2020
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Mohsen Sadatsafavi, James McCormack, John Petkau, Larry D. Lynd, Tae Yoon Lee, Don D. Sin. Should the number of acute exacerbations in the previous year be used to guide treatments in COPD?. Eur Respir J, 57 (2) 2002122; 10.1183/13993003.02122-2020

Member's Comments

No comment yet.

Related content which might interest you: Can we use a biomarker to guide antibiotic treatment in severe COPD exacerbations? Source: Breathe, 15 (4) 353; 10.1183/20734735.0257-2019 Year: 2019 Can antibiotics prevent acute COPD exacerbation? A systematic review and meta-analysis Source: Annual Congress 2013 –COPD: acute exacerbations and others Year: 2013 One year experience with acute COPD assessment service (ACAS) for patients with acute exacerbations of COPD Source: Eur Respir J 2006; 28: Suppl. 50, 178s Year: 2006 Effect of exacerbation history and ICS use on outcomes in COPD patients from the TIOSPIR™ trial Source: International Congress 2015 – New data on established treatments for COPD Year: 2015 Can we personalize COPD treatment by exacerbation frequency and severity? Three years of follow-up Source: International Congress 2016 – In-patient and out-patient COPD management Year: 2016 Does having previous sputum results improve rationalisation of antimicrobial prescribing during acute exacerbations of COPD? Source: International Congress 2014 – Different interesting issues in respiratory infections: 2 Year: 2014 Under reporting acute exacerbation in patient with COPD: incidence and predictors? Source: Eur Respir J 2006; 28: Suppl. 50, 175s Year: 2006 Analysis of the frequency of COPD exacerbations in the ’real-life’ DACCORD study over a 2 year period Source: International Congress 2016 – Comorbidities and exacerbations in COPD Year: 2016 COPD in the time of COVID-19: an analysis of acute exacerbations and reported behavioural changes in patients with COPD Source: ERJ Open Res, 7 (1) 00718-2020; 10.1183/23120541.00718-2020 Year: 2021 A global survey conducted to determine frequency of exacerbations in COPD patients Source: Annual Congress 2013 –COPD treatment Year: 2013 Three practical case studies on COPD using a remote voting system: 2. At hospital: NIV for acute exacerbation of COPD Source: Annual Congress 2013 –Management of COPD with NIV Year: 2013 Sit-to-stand ability in patients hospitalised for acute exacerbation of COPD: Clinical characteristics and short-term outcomes Source: International Congress 2015 – New insights into exercise and muscle performance Year: 2015 Difficulty in management of COPD exacerbation: Is this chronic exacerbation or difficult COPD: “A specific phenotype?” Source: Annual Congress 2013 –COPD biomarkers Year: 2013 Should we use early NIV in the ward for COPD exacerbations? Source: International Congress 2016 – Yernault Lecture preceded by the symposium “Latest developments in noninvasive ventilation: improvements and gadgets” Year: 2016 Early discharge for patients with exacerbations of COPD - a real life cohort study Source: Annual Congress 2005 - COPD - acute exacerbations Year: 2005 COPD exacerbation phenotypes in a five year hospitalisation cohort Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD? Year: 2018 Does past experience predict future exacerbations in adults with asthma? Source: Annual Congress 2010 - Therapy and health economics of asthma and COPD Year: 2010 Does influenza vaccination increase consultations for corticosteroid prescriptions or exacerbations of asthma or chronic obstructive pulmonary disease? Source: Annual Congress 2003 - COPD: risk factors and course of disease Year: 2003 Systematic review: Does antibiotic treatment duration affect the outcomes of asthma and COPD exacerbations? Source: International Congress 2017 – COPD: microbiome composition and the role of antibiotics Year: 2017 May the value of FEV1 be helpful in the choice of the antibiotic therapy in acute exacerbation of COPD? Source: Eur Respir J 2001; 18: Suppl. 33, 189s Year: 2001